Galectin Therapeutics
GALT
#8462
Rank
โ‚น25.14 B
Marketcap
โ‚น249.26
Share price
-4.27%
Change (1 day)
-48.00%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2026 (TTM): -โ‚น42.60

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น43.55. In 2025 the company made an earnings per share (EPS) of -โ‚น44.48 an increase over its 2024 EPS that were of -โ‚น70.42.

EPS history for Galectin Therapeutics from 2001 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น42.60-4.21%
2025-โ‚น44.48-36.84%
2024-โ‚น70.422.7%
2023-โ‚น68.5713.85%
2022-โ‚น60.2325%
2021-โ‚น48.1826.83%
2020-โ‚น37.995.13%
2019-โ‚น36.142.63%
2018-โ‚น35.21-22.45%
2017-โ‚น45.40-35.53%
2016-โ‚น70.42-13.64%
2015-โ‚น81.5412.82%
2014-โ‚น72.27-40%
2013-โ‚น120.4680.56%
2012-โ‚น66.72-32.08%
2011-โ‚น98.2213.98%
2010-โ‚น86.17-22.5%
2009-โ‚น111.19185.71%
2008-โ‚น38.92-70.83%
2007-โ‚น133.43118.18%
2006-โ‚น61.16-54.17%
2005-โ‚น133.43-14.29%
2004-โ‚น155.6747.37%
2003-โ‚น105.63-13.64%
2002-โ‚น122.31-24.14%
2001-โ‚น161.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
-โ‚น1,132 2,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-โ‚น12.05-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA